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The identification of regulatory elements from different cell types is necessary for understanding the mechanisms
controlling cell type–specific and housekeeping gene expression. Mapping DNaseI hypersensitive (HS) sites is an
accurate method for identifying the location of functional regulatory elements. We used a high throughput method
called DNase-chip to identify 3,904 DNaseI HS sites from six cell types across 1% of the human genome. A significant
number (22%) of DNaseI HS sites from each cell type are ubiquitously present among all cell types studied.
Surprisingly, nearly all of these ubiquitous DNaseI HS sites correspond to either promoters or insulator elements: 86%
of them are located near annotated transcription start sites and 10% are bound by CTCF, a protein with known
enhancer-blocking insulator activity. We also identified a large number of DNaseI HS sites that are cell type specific
(only present in one cell type); these regions are enriched for enhancer elements and correlate with cell type–specific
gene expression as well as cell type–specific histone modifications. Finally, we found that approximately 8% of the
genome overlaps a DNaseI HS site in at least one the six cell lines studied, indicating that a significant percentage of
the genome is potentially functional.
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Introduction
Biological processes such as proliferation, apoptosis,
differentiation, development, and aging require carefully
orchestrated spatial and temporal gene expression [1,2]. To
understand the molecular mechanisms that underlie global
transcriptional regulation, it is essential to identify all the
DNA regulatory elements in the human genome. Three
methods, DNaseI hypersensitive site (HS) mapping, chroma-
tin immunoprecipitation followed by hybridization to tiled
arrays (ChIP-chip), and expression arrays identify gene
regulatory elements in different ways. DNaseI HS sites
identify regions of open chromatin, which encompass all
different types of regulatory elements, including promoters,
enhancers, silencers, insulators, and locus control regions
(LCR) [3]. However, DNaseI HS mapping does not directly
reveal the transcription factor(s) that bind within each
DNaseI HS site. ChIP-chip directly identiﬁes the global
locations of regulatory factors [4–6], but this method can
only be used to study known factors and requires high quality
ChIP-grade antibodies. In addition, expression arrays detect
genes that are expressed in certain cell types, but do not
provide information regarding the factors that cause the cell
type–speciﬁc expression. Therefore, to completely under-
stand how chromatin structure ultimately regulates gene
expression, a multi-pronged integrated experimental ap-
proach using all three methods is needed.
We previously used DNase-chip to identify DNaseI HS sites
from two cell types across the 1% of the human genome
identiﬁed by the ENCODE consortium [4]. DNase-chip is a
method that works by capturing DNase digested ends,
labeling, and hybridizing the material to tiled microarrays.
This method is highly sensitive and speciﬁc when used to
identify valid DNaseI HS sites.
To identify the regulatory elements that control cell type–
speciﬁc and housekeeping gene expression, we have now
performed DNase-chip on the same 1% of the genome from
six diverse human cell types: CD4
þ T cells, GM06990 (B
lymphoblastoid), K562 (erythroleukemia), H9 (undifferenti-
ated embryonic stem cell), IMR90 (fetal lung ﬁbroblast), and
HeLa S3 (cervical carcinoma). In this study, we ﬁnd that
approximately 22% of all DNaseI HS sites from each cell type
are ubiquitously present in all six cell types, while the
remainder are a mixture of cell type speciﬁc (only present in
one cell type) or common (present in two to ﬁve cell types).
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performed computational analyses to integrate the DNase
data with the ChIP-chip data for two distinct enhancer-
binding proteins, one insulator-binding protein, and ﬁve
histone modiﬁcations, as well as expression data from the
same six cell lines. The majority (86%) of ubiquitous DNaseI
HS sites are within 2 kb of a transcription start site (TSS).
Surprisingly, of the remaining ubiquitous HS sites that are
distal to TSS, the majority (70%) are bound by CTCF, a factor
with known enhancer-blocking activity [7], suggesting that a
major role of ubiquitously modiﬁed chromatin is to prevent
misregulation by local enhancers. In contrast, cell type–
speciﬁc HS sites are correlated with known enhancer
elements [8] and histone-modiﬁed regions in a cell type–
speciﬁc manner. Cell type–speciﬁc DNaseI HS sites also
contain overrepresented sequence motifs that are biologically
relevant and often map near the TSS of genes that exhibit cell
type–speciﬁc expression. Collectively, these results show that
ubiquitous chromatin structures are predominantly associ-
ated with promoters and insulators while enhancers tend to
associate with cell type–speciﬁc chromatin structures.
Results
Assessing Data Quality
For each cell type, DNase-chip data was generated using
three concentrations of DNase on each of three biological
replicates (See Figure S1 for correlation plots). Averaged data
from all replicates (Figure 1A) was used for subsequent
analyses, because we have previously shown that averaging
data from replicate datasets generates higher sensitivity and
speciﬁcity [4]. Similar numbers of DNaseI HS sites were
identiﬁed from each cell type, indicating data consistency
(Table 1). To determine speciﬁcity for each cell line, we
determined the overlap of DNase signal from previously
reported ‘‘gold standard’’ negative sets of DNaseI HS sites for
CD4
þ T cells and GM06990 cell lines using real time PCR [4],
Figure 1. Identification of DNaseI HS Sites from Six Cell Types
(A) Representative DNase-chip data from ENCODE region ENr231 (Chr1:148050000–148165000). Note that there are common, ubiquitous, and cell type–
specific DNaseI HS sites.
(B) DNase-chip from K562 cells identifies all five LCR DNaseI HS sites upstream of the b-globin locus, as well as the 39 DNaseI HS site (in red). There are
additional DNaseI HS sites identified around promoter regions of the globin genes.
doi:10.1371/journal.pgen.0030136.g001
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Author Summary
There are many different types of gene regulatory elements that
control gene expression. Identifying the location of these regulatory
elements in the genome, as well as understanding how exactly they
control gene expression in different cell types, has been a major
challenge. Here, we use a relatively new strategy to identify all gene
regulatory elements within a select 1% of the human genome from
six diverse human cell types. We find that only 22% of gene
regulatory elements are shared among all cell types studied. Among
these, 86% are located near annotated transcription start sites and
10% are bound by CTCF, a protein with known enhancer-blocking
insulator activity. The gene regulatory elements that are found to be
cell type specific are highly correlated with cell type–specific gene
expression as well as cell type–specific chromatin modifications. This
indicates that we have made a significant step toward under-
standing why some genes are expressed in all different cell types
within the human body, and why others are only expressed in
certain cell types.and calculated .92% speciﬁcity for all six cell lines (Table 1).
As a second measure of speciﬁcity, we determined the
numbers of signiﬁcant signals that are detected in two
ENCODE regions (ENr112 and ENr313) that are depleted
for TSS, DNaseI HS sites, active histone modiﬁcations, and
ChIP-chip signals. Signiﬁcant signals that map within these
two regions are considered likely false positives. For each cell
line, only a few signiﬁcant signals were observed in these two
regions, which also indicates high speciﬁcity (Table 1). We
have previously shown that sensitivity of DNase-chip experi-
ments from CD4
þ T cells and GM06990 was .86% [4]. To
assess the sensitivity of these additional cell lines, we
examined ﬁve well-characterized DNaseI HS sites that make
up the globin locus control region [9,10]. We robustly detect
all ﬁve DNaseI HS LCR sites in K562 cells, as well as the well-
characterized 39 DNaseI HS site [11] (Figure 1B). In addition,
results from all six cell lines show a signiﬁcant enrichment for
TSS and CpG islands, one of the hallmarks of active
chromatin (Table 1 and unpublished data). Together, these
results indicate that the sensitivity and speciﬁcity in the four
newly studied cell lines are consistent with those in CD4
þ T
and GM06990 cells. All DNase-chip data described here is
publicly available on the University of California Santa Cruz
(UCSC) genome browser [12] (http://genome.ucsc.edu).
Properties of DNaseI HS Sites
Classiﬁcation by cell type. DNaseI HS sites are classiﬁed as
cell type speciﬁc (only found in one out of six cell lines),
common (found in two to ﬁve cell lines), or ubiquitous (found
Figure 2. Identification and Characterization of DNaseI HS Sites
(A) Clustering of six cell lines based on DNaseI HS site profiles. ENCODE regions were divided into 2-kb blocks and a binary DNaseI HS site profile was
calculated for each cell line (1 for blocks containing a DNaseI HS sites hit, displayed in green, and 0 otherwise, uncolored). Cell lines were clustered
based on their DNaseI HS sites hit profiles using Wards hierarchical clustering [41] with Euclidian distance as the metric. Ubiquitous DNase sites are
grouped at the bottom.
(B) Cumulative percentage of the genome covered by DNaseI HS sites from increasing number of cell lines. Diamonds represent cumulative percentage
of the genome covered by DNaseI HS sites from any cell line. Triangles represent cumulative percentage of the genome overlapped by DNaseI HS sites
shared by at least two cell types. Each point is an averaged value of all possible cell line combinations.
(C) Location of DNaseI HS sites relative to TSS. DNaseI HS sites from IMR90 cells were first categorized as unique to IMR90, common with other cell
types, or ubiquitous in all six cell types. Data centering on other cell types are identical (unpublished data). Distances of each DNaseI HS site were
calculated to the nearest TSS.
(D) CpG dinucleotide distribution. The percentage of CG dinucleotide was determined for proximal and distal DNaseI HS sites that were unique to
IMR90, common with additional cell types, or ubiquitous within all six cell types.
doi:10.1371/journal.pgen.0030136.g002
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Chromatin Regulatory Structuresin all six cell lines) (Table 1; Figure 2A). Between any two cell
lines, fewer than 50% of DNaseI HS sites overlap. The highest
overlapping datasets were from the two lymphocyte cell lines,
CD4
þ and GM06690. On average for each cell type, 32% of
DNaseI HS sites are cell type speciﬁc, 46% are common, and
22% are ubiquitous. A total of 3,904 distinct DNaseI HS sites
were identiﬁed from the six cell types.
DNaseI HS sites and gene expression proﬁles show similar
lineage speciﬁcity. To test whether we can determine cell type
speciﬁcity from DNaseI HS sites, we compared cluster
dendrograms from both DNaseI HS sites and expression
data. Both dendrograms have the closest clustering occurring
between CD4
þT cell and GM06990 B lymphoblastoid (Figures
2A and S2). This is to be expected, as these two cell types are
derived from a common lymphoid progenitor. Interestingly,
K562, which is an erythroleukemia cell line, does not cluster
closely with CD4
þ T and GM06990 using either DNase or
expression data. However, other studies have shown that
K562 cells have characteristics distinct from B and T cells
[13].
Determining DNaseI HS site saturation. To determine
whether we have identiﬁed most DNaseI HS sites in the
ENCODE regions, we computed the cumulative percentage of
base pairs as a function of the number of cell lines tested. As
additional cell lines are included, the total percentage of base
pairs of the ENCODE regions covered by DNaseI HS sites
increases steadily, reaching ;8% at six cell lines (Figure 2B).
We wanted to know whether the new sites are predominantly
those that are unique to one cell type. DNaseI HS sites that
are observed in only one cell type tend to be less sensitive to
DNaseI cleavage and hence may be more affected by
microarray noise than sites observed in multiple cell types.
Nonetheless, as discussed in the last section of Results, cell
type–speciﬁc DNaseI HS sites are enriched in the regions
bound by enhancer proteins and regions with modiﬁed
histones, thus, they contain bone ﬁde regulatory elements. We
do not detect a signiﬁcant leveling off after the addition of
the sixth cell type, even if we only analyze DNaseI HS sites
that are common in at least two cell types. This indicates that
additional cell lines must be tested in the future to identify
most DNaseI HS sites.
Location of DNaseI HS sites relative to genes. We
calculated the distance of DNaseI HS sites to the nearest
TSS, with the TSS set deﬁned in a comprehensive way by the
Integrated Analysis group of the ENCODE consortium [14]
(Figure 2C). Thirty-four percent of cell type–speciﬁc DNaseI
HS sites are proximal to a TSS (,2 kb). In stark contrast, 86%
of ubiquitous DNaseI HS sites are proximal to TSS. The
distribution of proximal DNaseI HS sites in terms of the
numbers of tissues in which they occur is signiﬁcantly
different from those of other DNaseI HS site categories in
Figure 2C (p-value , 2.2 3 10
 16 by Wilcoxon test). The
dramatic increase in proximal DNaseI HS sites in six cell lines
over ﬁve cell lines indicates the high quality of the DNase
data, because one would expect a more gradual shift for data
with low sensitivity and speciﬁcity. While proximal DNaseI
HS sites are overrepresented in the genome, distal DNaseI HS
sites are underrepresented and become increasingly under-
represented the further away from the TSS (Figure S3).
Therefore, distal DNaseI HS sites are not uniformly dis-
tributed in the genome but instead are located closer to
genes.
CpG dinucleotide distribution. Because CpG islands are
generally associated with housekeeping promoters of mam-
malian genes, we asked whether the percentage of CpG
dinucleotides differs among unique, common, and ubiquitous
DNaseI HS sites. Cell type–speciﬁc DNaseI HS sites tend to
have similar percentages of CG dinucleotides regardless of
whether the DNaseI HS sites are proximal (,2 kb) or distal
(.2 kb) to a TSS (Figure 2D). DNaseI HS sites that are
common to more cell types are more CpG rich than cell type–
speciﬁc sites, and the slope of this increase is much greater
for proximal sites than for distal sites (Figure 2D). A similar
but more moderate trend is detected for GþC mononucleo-
tide (Figure S4).
Ubiquitous Proximal DNaseI HS Sites
For the 222 proximal DNaseI HS sites (,2 kb from TSS)
that are ubiquitous in all six cell lines, 78% overlap recently
published ChIP-chip data speciﬁc to basal promoter factors
(RNA PolII and TAF1) [15], enhancers (p300 and TRAP220)
[8], or the insulator factor CTCF [16] (Figure 3A and 3B). The
majority (81%) of DNaseI HS sites bound by p300 or
TRAP220 also bind Pol II or TAF1. However, only 22%
DNaseI HS sites bound by CTCF are also bound by TAF1 or
Pol II, suggesting that CTCF binding to the promoter
decreases the likelihood of binding by other factors exam-
ined. For the ubiquitous proximal DNaseI HS sites that do
not overlap known promoter factors, 53% overlap with the
Table 1. DNase-Chip Statistics for Different Cell Lines
DNaseI HS site categories CD4 GM06990 K562 H9 HeLa IMR90
Number of DNase I chip hits identified 1262 1098 1210 1274 1042 1244
Specificity based on TSS-depleted ENCODE regions .99.9% .99.9% 99.5% 99.8% 99.7% 99.8%
Specificity based on ‘‘gold standard’’ negative DNaseI HS sites (n ¼ 134) 97% 99% 96% 95% 96% 92%
Number of proximal DNaseI HS sites 784 674 666 773 575 642
Number of distal DNaseI HS sites 478 424 538 498 464 599
Number of DNaseI HS sites containing a TSS 402 352 357 432 318 362
Number of cell line specific DNaseI HS sites 439 341 448 400 277 463
Number of ubiquitous DNaseI HS sites
a 262 262 266 273 262 259
aThe number of ubiquitous DNaseI HS sites from each cell type varies slightly due to a small number of circumstances in which one cell type has a single large DNaseI HS site, while
another cell type has broken up this region into two smaller DNaseI HS sites.
doi:10.1371/journal.pgen.0030136.t001
PLoS Genetics | www.plosgenetics.org August 2007 | Volume 3 | Issue 8 | e136 1380
Chromatin Regulatory StructuresChIP hits of H3K4me3, a histone modiﬁcation mark for active
promoters (Figure 3A) [17].
Ubiquitous Distal DNaseI HS Sites
The majority of distal ubiquitous DNaseI HS sites contain
insulators. Of the 259 DNaseI HS sites that are ubiquitous in
all six cell lines, 37 are distal (.2 kb) to a TSS. To identify the
protein(s) that putatively bind to these regions, the minimal
intersecting region for each ubiquitous site was analyzed by
the de novo motif-ﬁnding algorithm MEME [18]. The most
signiﬁcant motif (p-value , 2.2310
 16; Figure 4A) was not in
the TRANSFAC [19] or Jaspar [20] databases, but is nearly
identical to the motif recently discovered in a genome-wide
ChIP-chip study with an antibody against CTCF in IMR90
cells [16]. Using this ChIP-chip data, we ﬁnd that 70% (26/37)
of the ubiquitous distal DNaseI HS sites overlap with CTCF
binding sites (Figure 4B; Tables S1 and S2). An additional
four ubiquitous distal DNaseI HS sites that do not overlap
with CTCF hits contain the CTCF motif. Some of these 26
distal ubiquitous sites that overlap CTCF are clustered in the
genome. For example, three DNaseI HS sites are in the IGF2/
H19 locus (ENCODE region ENm011), clearly isolating the
H19, IGF2, and TH genes (Figure 4C). The well-characterized
imprinting insulator between H19 and IGF2 [21] is not one of
these three; however, it overlaps with a DNaseI HS site that is
present in ﬁve cell lines. In addition, four ubiquitous DNaseI
HS sites overlap CTCF hits in the HoxA locus (Figure S5).
The CTCF motif is predictive of CTCF binding. The CTCF
motif can be found in 88 (55%) of the 160 DNaseI HS sites
that overlap with CTCF hits (p-value cutoff of 10
 5 as
computed by the MAST algorithm [22]; Table S2). Most
(85%) of these 88 DNaseI HS sites contained only a single
CTCF motif site. DNaseI HS sites that contain two (n¼23) or
three motifs (n ¼ 4) were not more enriched for CTCF ChIP-
chip hits (unpublished data), indicating a single CTCF motif is
sufﬁcient to facilitate signiﬁcant CTCF binding. CTCF motif
sites in both distal and proximal DNaseI HS sites are
signiﬁcantly more conserved than neighboring genomic
regions based on phastCons [23] conservation scores (Figure
S6). Approximately 19% of DNaseI HS sites in IMR90 that do
not overlap CTCF ChIP-chip data (139/1084) contain the
CTCF motif (Table S2). Although these CTCF motif sites are
on average less conserved than those that overlap CTCF
ChIP-chip hits (Figure S6), the subset in distal DNaseI HS sites
are still signiﬁcantly more conserved than neighboring
genomic regions (leftmost bar in Figure S6), indicating that
they may bind CTCF in living cells.
DNaseI HS sites contain functional enhancer-blocking
elements. We performed cell culture enhancer-blocking
assays [7] on seven CTCF motif-containing DNaseI HS sites;
six of these are ubiquitous and the other one is common in
ﬁve cell types (Table S3). All seven clones display signiﬁcant
enhancer-blocking activity (Figure 4D; p-value ¼ 0.002),
including the DNaseI HS site that does not overlap a CTCF
ChIP-chip hit (DHS4). Three of the DNaseI HS sites are
proximal to TSS (DHS1, DHS4, and DHS6). Although we only
tested a small number of DNaseI HS sites, our results indicate
that DNaseI HS sites that occur in many cell types and
contain the CTCF motif are likely functional insulators. In
addition, proximal DNaseI HS sites near TSS can also
function as insulators.
CTCF is preferentially bound to ubiquitous and common
DNaseI HS sites. Of the 225 CTCF ChIP-chip hits that map
within ENCODE regions, 160 (71%) overlap with DNaseI HS
sites identiﬁed in IMR90 cells. The percentage of DNaseI HS
sites that overlap CTCF ChIP-chip hits steadily increases for
DNaseI HS sites that are more common, with the highest
percentage occurring within ubiquitous DNaseI HS sites
(Figure 5). This is in contrast to the binding sites for p300 and
Figure 3. Ubiquitous Proximal DNaseI HS Sites Overlap with Known Factors
(A) Chart identifying the different factors that overlap 222 ubiquitous DNaseI HS sites that map to TSS, including RNA Pol II, TAF1, TRAP220, p300, CTCF,
and the H3K4me3 histone mark. Red indicates overlap with CTCF, green indicates overlap with other marks, and unfilled boxes represent no overlap.
(B) Pie chart representing the percentage of ubiquitous DNaseI HS sites that overlap with various factors (histone modifications not shown for clarity
purposes).
doi:10.1371/journal.pgen.0030136.g003
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Chromatin Regulatory StructuresFigure 4. The CTCF Motif Is Identified in Ubiquitous Distal DNaseI HS Sites
(A) Motif identified using de novo motif-finding algorithm using the minimal intersecting regions of ubiquitous distal DNaseI HS sites. The overall height
of the stack of letters in a position indicates the sequence conservation at that position, while the height of letters within the stack indicates the relative
frequency of each base at that position.
(B) Percentage of ubiquitous distal DNaseI HS sites that overlap with CTCF ChIP-chip data, CTCF motif, or other enhancer elements.
(C) Example of clustered ubiquitous DNaseI HS sites that overlap CTCF in the H19/IGF2 locus. Arrows indicate ubiquitous DNaseI HS sites overlapping
with CTCF.
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Chromatin Regulatory StructuresTRAP220, proteins with enhancer activity, which are prefer-
entially detected in cell type–speciﬁc and less common
DNaseI HS sites (Figure 5). This indicates that insulators,
but not enhancers, comprise the majority of ubiquitous distal
regulatory elements.
Cell Type–Specific and Common DNaseI HS Sites
DNaseI HS sites colocalize with histone-modiﬁed regions in
a cell line–speciﬁc manner. Previously, ChIP-chip for ﬁve
histone modiﬁcations (H3K4me2, H3K4me3, H3ac, and H4ac)
was performed on three cell lines (HeLa, GM06990, and K562)
and ChIP-chip for H3K4me1 was performed on two cell lines
(HeLa and GM06990) [17]. We calculated the number of
DNaseI HS sites that overlap ChIP-chip hits for each histone
modiﬁcation in 3-by-3 cell line combinations (2-by-2 in the
case of H3K4me1). Ubiquitous DNaseI HS sites often overlap
with ubiquitous histone modiﬁcation hits, in particular with
H3K4me3 and H3ac, which are strong markers for the 59 ends
of active genes. This is consistent with our aforementioned
results indicating that 86% ubiquitous DNase HS sites are
promoters. Respectively, there are 78 and 103 ubiquitous
H3K4me3 and H3ac hits in the ENCODE regions; 59 and 80
of them overlap with ubiquitous DNaseI HS sites, respec-
tively. Ubiquitous DNaseI HS sites and ubiquitous histone
modiﬁcation hits were excluded from the remaining analysis
in this section, because they merely increase all counts of
overlap. The counts were divided by the corresponding row
sum and column sum and multiplied by the matrix sum to
obtain enrichment values, which is done in the same way as
the v
2 test (see Figure S7 for detailed explanation). In Figure
6A and 6B, we plot the enrichment factor for H3K4me2 in a
3-by-3 grid (see Figure S8 for other histone modiﬁcations).
The diagonal matched cell line enrichment values (all .1) are
much larger than off-diagonal mismatched cell line values
(,1 for all comparisons except H3ac in the K562-HeLa
comparison), indicating that DNaseI HS and ChIP-chip
experiments are both detecting similar genomic regions that
reﬂect cell type speciﬁcity. This agreement is particularly
striking given that the DNaseI HS and ChIP-chip experiments
were performed in different labs and on different microarray
platforms [17] (the histone modiﬁcation experiments were on
spotted PCR arrays).
DNaseI HS sites colocalize with p300-binding regions in a
cell line–speciﬁc manner. We performed overlap analysis on
DNaseI HS sites and p300 ChIP-chip hits in three cell types
(HeLa, K562, and GM06990), in the same way as described
above for histone modiﬁcations. Again, ubiquitous DNaseI
HS sites and ubiquitous p300 hits were excluded from this
analysis. The results are shown in Figure 6C and 6D, for
proximal and distal DNaseI HS sites separately, both
indicating strong colocalization.
Cell type–speciﬁc DNaseI HS sites colocalize with cell type–
speciﬁc gene expression. We hypothesized that cell type–
speciﬁc DNaseI HS sites are involved in cell type–speciﬁc
gene regulation, and therefore expected them to colocalize
with (within 2 kb of) the TSS of genes active in the
corresponding cell line. Because only a few genes were
strictly expressed exclusively in one cell line within the
ENCODE regions, the deﬁnition of cell type–speciﬁc genes
was relaxed to include genes expressed in no more than two
cell lines in addition to the cell line of interest. The 6-by-6
enrichment matrix (Figure 6E) was constructed in the same
way as described above for histone modiﬁcations. The
diagonal enrichment values (matched cell lines) are larger
than off-diagonal values (mismatched cell lines), indicating
that cell type–speciﬁc DNaseI HS sites tend to colocalize with
genes that are expressed in the corresponding cell types (p-
value ¼ 1.15 3 10
 4 by Wilcoxon ranked sum test). The
signiﬁcance is maintained if we loosen the proximity criteria
to DNaseI HS sites that are within 5 kb or 10 kb of a cell type–
speciﬁc TSS (unpublished data).
Cell type–speciﬁc DNaseI HS sites are enriched for
biologically relevant motifs. To identify putative regulatory
factors that bind cell type–speciﬁc DNaseI HS sites, we
analyzed these sites with Clover [24], a motif-ﬁnding
algorithm that identiﬁes motifs from the TRANSFAC data-
base that are enriched in a set of sequences, namely the
DNaseI HS sites speciﬁc to a cell type. We used two sets of
background sequences for computing the enrichment: the
union set of all ChIP-chip hits generated by the ENCODE
Transcription Regulation group at the 5% false discovery
rate cutoff [14], and random dinucleotide shufﬂing of the
input sequence set (DNaseI HS sites speciﬁc to a cell line). We
obtained similar results from both sets of background
sequences. Motifs enriched in each cell line were identiﬁed
for DNaseI HS sites proximal or distal relative to the TSS
(Table 2). Many of the overrepresented motifs are function-
ally relevant to the cell type from which the DNase data was
generated. For example, the TAL1 motif [25,26], enriched in
CD4
þ T speciﬁc DNaseI HS sites, binds a well-known
transcription activator involved in hematopoietic stem cell
function and the development of T cell acute lymphoblastic
leukemia [27]. K562 DNaseI HS sites are enriched for the
GATA1 motif, which is a factor known to be involved in
erythroid maturation [28]. H9 ES cell DNaseI HS sites are
enriched for the Octamer [29], Sox, and STAT family motifs,
(D) Cell culture insulator assays demonstrate that DNaseI HS sites (that overlap CTCF) display enhancer-blocking activity. Higher colony counts in G418
media indicate no enhancer-blocking activity, while lower colony counts indicate positive enhancer-blocking activity. A previously described chicken
insulator was used as a positive control [11].
doi:10.1371/journal.pgen.0030136.g004
Figure 5. Percentage of Distal Unique, Common, or Ubiquitous DNaseI
HS Sites That Overlap with CTCF, p300, and TRAP220
CTCF binding makes up a greater percentage of more common and
ubiquitous distal DNaseI HS sites, while p300 and TRAP220 binding
makes up a greater percentage of cell type–specific and less-common
DNaseI HS sites.
doi:10.1371/journal.pgen.0030136.g005
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Chromatin Regulatory Structureswhich have been reported to be involved in pluripotency and
early differentiation [30,31]. The AP-1 motif [32] is enriched
in HeLa DNaseI HS sites [33]. AP-1 is especially enriched in
those HeLa DNaseI HS sites that overlap with p300 ChIP-chip
hits (p-value , 2.2 3 10
 16 by v
2 test; Table S4). The AP-1
components, c-jun and c-fos, are among the many proteins
known to interact with p300 [34]. Because the AP-1 motif is
the most enriched motif in p300 ChIP-chip hits (unpublished
data), this suggests that AP-1 contributes to the DNA binding
speciﬁcity of p300.
Discussion
We present DNase-chip data from six cell lines and classify
the DNaseI HS sites into cell type–speciﬁc, common (found in
more than one but not all cell lines), and ubiquitous
categories. Only 22% of all DNaseI HS sites are ubiquitous
in all cell lines, indicating that the majority of gene regulatory
elements are involved in cell type–speciﬁc function.
The identiﬁcation of ubiquitous DNaseI HS sites provides
clues to the function of housekeeping chromatin structures
that are maintained in most cell types. We detected 259 such
ubiquitous sites in the ENCODE regions. Approximately 86%
of ubiquitous DNaseI HS sites are proximal to TSS and map
to basal transcription factor binding sites, indicating that
these regions function as housekeeping promoters. The
majority of ubiquitous distal DNaseI HS sites bind to CTCF,
a protein with known enhancer-blocking insulator activity [7],
indicating that CTCF is involved in stable chromatin
structure and gene expression maintenance across many cell
Figure 6. DNaseI HS Sites Colocalize with Histone Modifications, p300 Binding, and Gene Expression in a Cell Type–Specific Manner
The enrichment factors of proximal (A) or distal (B) DNaseI HS sites with H3K4me2 ChIP-chip hits from three different cell types. The enrichment factors
of proximal (C) or distal (D) DNaseI HS sites with p300 ChIP-chip hits. (E) Cell type–specific DNaseI HS sites (y-axis) are mapped relative to transcription
start sites of genes with cell type–specific expression (x-axis). Size of bubbles represents the enrichment. When no bubble is present, the value is zero
(complete depletion).
doi:10.1371/journal.pgen.0030136.g006
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Chromatin Regulatory Structurestypes. Because most ubiquitous sites bind to either basal
transcription machinery or CTCF, we conclude that ubiq-
uitous DNaseI HS sites function primarily as promoters and
insulators, but not enhancers. Cell type–speciﬁc DNase HS
sites, however, are more enriched for protein binding sites
with known enhancer activity, cell type–speciﬁc histone
modiﬁcations, and cell type–speciﬁc gene expression.
Although our DNaseI HS site data was limited to 1% of the
human genome, the integration over multiple data types
allowed us to conclude that we have uncovered many
different types of functional regulatory elements. In the
future, as additional cell types are analyzed using whole
genome DNase-chip, we will be able to better characterize
DNaseI HS sites that are truly cell type speciﬁc, as well as
those that are shared between cell types of similar lineages.
We expect that genome-wide analysis from additional cell
types, under different cellular conditions, or at different
developmental stages, will provide for more powerful de novo
motif discovery, similar to our identiﬁcation of CTCF, for
identifying and characterizing unknown factors that regulate
temporal and spatial gene expression.
Our integrated approach combines the strengths of four
high-throughput technologies (DNase-chip, ChIP-chip, ex-
pression array, and motif discovery). DNase-chip can identify
all types of regulatory elements in a single experiment and
integration with other datasets has allowed us to delineate the
functions of subsets of DNaseI HS sites. This approach will be
increasingly more powerful as more high-throughput datasets
become available and will be an important part of ensuring
that no regulatory element is missed. Nonetheless, our
analysis is missing an important component—we cannot
identify the target gene(s) of a DNaseI HS site. Technologies
such as chromosome conformation capture carbon copy (5C)
[35] are ideal for detecting large numbers of long-range
interactions between genomic elements. Since 5C works best
by anchoring to known regulatory elements, DNaseI HS sites
identiﬁed in our study can be used to signiﬁcantly reduce the
search space.
DNaseI HS sites can be used as a general tool for evaluating
future ChIP-chip datasets that have been performed on only
one of the cell types described here, to determine whether
those factors bind genomic DNA in a cell type–speciﬁc or
ubiquitous manner. This is illustrated for the p300 ChIP-chip
data in Figure S9, which shows that the percentages of p300
binding (performed in HeLa cells) are highest for HeLa-
speciﬁc distal DNaseI HS sites. Other examples of cell line-
speciﬁc marks are H3K4me1 and H3K4me2 (Figure S9). In
contrast, H3K4me3, H3ac, H4ac, and CTCF show less cell line
speciﬁcity (Figure S10). Our DNaseI HS data can also be used
to help identify unknown transcription factors binding and
unknown histone modiﬁcation patterns. For example, only
60% of proximal DNaseI HS sites overlap with the ﬁve
histone modiﬁcations we examined in this study. Future
studies will be needed to identify the histone modiﬁcation(s)
that are associated with these regions.
While DNaseI HS sites from each cell type cover approx-
imately only 2%–3% of the genome, the combined DNase
data from six cell types covers roughly 8% of the genome.
Since the actual functional regulatory sequences (i.e., protein
binding sites) may make up a fraction of each DNase HS site,
the actual percentage of functional DNA may be smaller. As
we have not detected a signiﬁcant decrease in the number of
new DNaseI HS sites identiﬁed with the addition of each cell
type, this indicates that a large percentage of the genome may
be functional in all possible cell types, disease states, and
responses to external stimuli. Whole genome identiﬁcation of
Table 2. Tissue-Specific DNaseI HS Sites Are Enriched in Motifs Indicative of the Corresponding Cell Types
Cell Type TF Motif Group Proximal Distal Far Distal
CD4 TAL1 (T-cell acute lymphocytic leukemia)
[25,26], E2A, E12, AP-4, or Lmo2 complex
33
ETS family factors 33
GM06990 Lmo2 complex, Ebox, E12, or E47 33
T3R 3
IRF 3
PAX6 3
HeLa AP-1 [32], Nrf2, or Bach1 33 3
IPF1 33
NF-1 3
H9 ES Octamer [29] or Oct-1 3
Sp-1, KROX, or VDR 33
STAT1, STAT3, STAT6, or TEF-1 3
SOX-9 3
K562 GATA [28] 33 3
PR or GR 33
GEN_INI 33
Tel-2 3
IMR90 AP-4, Lmo2 complex, myogenin, MyoD, or LBP-1 33
STAT3, STAT5A, or Ets 33
AP-1 3
AR 3
ER 3
TEF-1 3
doi:10.1371/journal.pgen.0030136.t002
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Chromatin Regulatory Structuresall DNaseI HS sites using DNase-chip [4] or DNase-sequenc-
ing [36] methods will play a key role in identifying and
ultimately understanding the function of all functional
noncoding DNA sequences.
Materials and Methods
Identiﬁcation of DNaseI hypersensitive sites. DNase-chip was
performed as previously described [4]. Brieﬂy, intact nuclei were
digested with optimized amounts of DNase. DNase digested ends were
blunted, ligated to biotinylated linkers, sonicated, and enriched on a
streptavidin column. Sheared ends were blunted and ligated to
nonbiotinylated linkers. DNase-enriched material was ampliﬁed by
linker-mediated PCR, labeled, and hybridized to NimbleGen EN-
CODE arrays. Randomly sheared DNA was used as a reference
control. For each cell type, DNase-chip material was generated from
three biological replicates and three different DNase concentrations
(total of nine hybridizations per cell type). Raw ratio data from each
cell type was averaged and signiﬁcant signals were identiﬁed using
ACME (p-value ¼ 0.001). All DNase-chip data is publicly available on
the UCSC genome browser [12] (http://genome.ucsc.edu).
Embryonic stem cell culture. Human ES cell line H9 [37] (WiCell
Research Institute; National Institutes of Health Code WA09) was
cultured on a feeder layer of mitotically inactivated mouse embryo
ﬁbroblasts in medium consisting of DMEM-F12 supplemented with
20% KSR (Invitrogen, http://www.invitrogen.com), 5 ng/ml FGF2
(R&D Systems, http://www.rndsystems.com/), 2mM L-glutamine,
0.1mM 2-mercaptoethanol, and 13 nonessential amino acids. For
analysis, hES cell colonies were separated away from the feeder layer
and processed for DNaseI hypersensitive site mapping. The undiffer-
entiated state of the cultures was determined by morphology,
immunohistochemistry, and Affymetrix expression array (http://
www.affymetrix.com) analysis.
Expression arrays. Total RNA was extracted from CD4
þ T cells,
GM06990, HeLa S3, K562, and H9 undifferentiated stem cells using
Trizol (Invitrogen). RNA was analyzed by Bioanlyzer to conﬁrm high-
quality 18s and 28s ribosomal bands (Agilent, http://www.home.
agilent.com/), labeled, and hybridized to Affymetrix U133 Plus 2.0
arrays. The expression data for IMR90 was publicly available (http://
licr-renlab.ucsd.edu/download.html). All data was normalized togeth-
er using RMA [38] through the BioConductor project’s Affymetrix
package (http://www.bioconductor.org). Only genes expressed in the
ENCODE regions were used for the analysis. Gene expression was
categorized as expressed or not expressed by the Affymetrix A/P call.
Enhancer block cell culture assays. The enhancer blocking assay
was performed as described previously [7]. Brieﬂy, the b-globin
DNaseI HS2 site, which is a known enhancer element [39], was cloned
upstream of a NeoR gene. Putative insulators were cloned between
the enhancer and NeoR gene. The previously described chicken
insulator was used a positive control [40]. DNaseI HS sites proximal
or distal to TSS that also overlapped CTCF binding sites were cloned
into the enhancer block vector. All plasmids were puriﬁed from three
independent bacterial cultures, linearized, and each DNA prep was
electroporated independently into K562 cells. Each electroporation
was plated in triplicate (total of nine experiments per plasmid). The
next day, cells were transferred to soft agar media containing G418.
After 16 days, plates were scanned and colonies were counted.
ChIP and TSS data analysis. Publicly available ChIP-chip data of
CTCF, p300, RNA Pol II, TRAP220 was obtained from http://
licr-renlab.ucsd.edu/download.html. ChIP-chip data for ﬁve histone
modiﬁcations were obtained from the UCSC genome browser (http://
genome.ucsc.edu). The coordinates for TSS were obtained from the
ENCODE pilot study [14] (TSS set ABCDE deﬁned in supplement 3.5
therein). These data were mapped onto the DNaseI HS sites in each
cell line based on their overlapping coordinates. To determine
whether distal DNaseI HS sites are still statistically near genes, we
binned all DNaseI HS sites according to their distances to the closest
TSS. We computed an enrichment score for each bin, deﬁned as the
ratio between the number of DNaseI HS sites and the number of all
possible positions in the ENCODE regions in the same distance bin.
Motif identiﬁcation. MEME [18] with the ‘‘-zoop’’ option was used
to identify the CTCF sites in the ubiquitous distal DNaseI HS sites.
Clover [24] was used to identify motifs overrepresented in cell type–
speciﬁc DNaseI HS sites at each distance category: proximal (,2 kb),
distal (between 2 kb and 10 kb) and far distal (.10 kb). Two
background sets were used (union of ChIP-chip hits and random
dinucleotide shufﬂing of input sequences). Overrepresented motifs
(p-values , 0.01) from the TRANSFAC database were reported.
Overlapping motifs were reported as groups.
Supporting Information
Figure S1. Correlation Plots of DNase-Chip Data from Each of Three
Biological Replicates and Three Different DNase Concentrations
(Two Replicates and Four DNase Concentrations for H9)
Each correlation plot corresponds to raw ratio values from each
DNase-chip replicate (x-axis) compared to the averaged raw ratio
values of all DNase-chip replicates from each cell type (y-axis). The
Pearson correlation coefﬁcients (R) are shown at the bottom of each
plot. Correlation coefﬁcients are lower for CD4
þ T cells and the
GM06990 cell lines, but this data was previously shown by extensive
quantitative PCR validation [4] to have high sensitivity (88%) and
speciﬁcity (97%).
Found at doi:10.1371/journal.pgen.0030136.sg001 (619 KB TIF).
Figure S2. Clustering Dendrograms from Six Cell Types Using DNaseI
HS sites Is Similar to Clustering Using Gene Expression Data
Six cell lines were clustered using DNaseI HS sites data in the same
way as described in Figure 2A. For expression data, the Euclidian
distances are calculated from the Robust Multichip Average (RMA)
[38] normalized expression levels between each cell line for genes that
map within ENCODE regions. Other algorithms also cluster CD4
þ
and GM06990 ﬁrst, a sign that this grouping is robust and biological
(unpublished data). To test whether this was a result of analyzing
genes within 1% of the genome, we performed the same clustering
using genome-wide expression data and ﬁnd that CD4
þ T and
GM06990 cells remain the closest-clustering cell lines, while K562
remains more distantly clustered (unpublished data).
Found at doi:10.1371/journal.pgen.0030136.sg002 (635 KB TIF).
Figure S3. DNaseI HS Sites Are Enriched for Gene-Rich Regions of
the Genome
For each cell line, DNaseI HS sites were assigned to distance bins
based on the distances to the nearest transcription start site (TSS).
Similarly, each genomic position in the ENCODE regions is assigned
to a bin based on its distance to the nearest TSS. To calculate the
enrichment of DNase sites, the percentage of DNaseI HS sites in each
distance bin is normalized by the percentage of positions in each
distance bin. DNaseI HS sites near TSS were enriched and DNaseI HS
sites were less likely to be found at large distances from a TSS.
Found at doi:10.1371/journal.pgen.0030136.sg003 (279 KB TIF).
Figure S4. GC Content for Proximal and Distal DNaseI HS Sites That
Are Unique to IMR90 Cells, Common to IMR90 Plus Additional Cell
Types, and Ubiquitous to All Six Cell Types
Found at doi:10.1371/journal.pgen.0030136.sg004 (272 KB TIF).
Figure S5. Ubiquitous DNaseI HS Sites within the HoxA Locus
Overlap with CTCF Binding
Arrows represent ubiquitous DNaseI HS sites.
Found at doi:10.1371/journal.pgen.0030136.sg005 (776 KB TIF).
Figure S6. Distribution of PhastCons Scores for CTCF Motifs of
Different Categories
The y-axis is the percentage of base pairs with phastCons scores of
different ranges. PhastCons takes a multiple sequence alignment, a
phylogenetic model for conserved regions, and a phylogenetic model
for nonconserved regions as input. It scans along for regions that
better ﬁt the conserved model than the nonconserved model and
output the probability that each base is in such a region as the
conservation score for that base. The categories are: ‘‘Distal non-
overlap,’’ CTCF motifs located in distal DNaseI HS sites (greater than
2 kb from any TSS) that do not overlap with CTCF ChIP chip hit
regions; ‘‘Distal overlap,’’ CTCF motifs located in distal DNaseI HS
sites that overlap with CTCF hit regions; ‘‘Proximal non-overlap,’’
CTCF motifs located in proximal DNaseI HS sites (less than 2 kb from
a TSS) that do not overlap with CTCF hit regions; and ‘‘Proximal
overlap,’’ CTCF motifs located in proximal DNaseI HS sites that
overlap with CTCF hit regions. For each category, the genomic
regions 100 bp downstream from the motif coordinates were used as
the control.
Found at doi:10.1371/journal.pgen.0030136.sg006 (1.0 MB TIF).
Figure S7. Step-by-Step Illustration for Computing the Enrichment
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Chromatin Regulatory Structuresof the Overlap between Common or Cell Type–Speciﬁc Distal DNase
HS Sites and Common or Cell Type–Speciﬁc ChIP-Chip Hits
Shown here is an example using H3K4me2 data (the ﬁnal matrix is
plotted in Figure 6B).
Found at doi:1!0.1371/journal.pgen.0030136.sg007 (667 KB TIF).
Figure S8. Cell Type–Speciﬁc DNaseI HS Sites Colocalize with Cell
Type–Speciﬁc Histone Modiﬁcations (H3K4me1, H3K4me3, H3ac,
and H4ac)
Each plot shows the enrichment of the overlap between proximal or
distal DNaseI HS sites and each histone modiﬁcation hit from three
different cell types. See main text for the enrichment of H3K4me2
and the description of the enrichment calculation.
Found at doi:10.1371/journal.pgen.0030136.sg008 (3.5 MB TIF).
Figure S9. Transcription Factors and Histone Modiﬁcations That
Display Strong Cell Type–Speciﬁc Binding
ChIP-chip from HeLa cells are compared to proximal and distal
DNaseI HS sites that are unique to HeLa cells, common, or
ubiquitous to all six cell types.
Found at doi:10.1371/journal.pgen.0030136.sg009 (2.7 MB TIF).
Figure S10. Transcription Factors and Histone Modiﬁcations That
Display Weak Cell Type–Speciﬁc Binding
ChIP-chip from HeLa and IMR90 cells are compared to proximal and
distal DNaseI HS sites that are unique to HeLa or IMR90 cells,
common, or ubiquitous to all six cell types.
Found at doi:10.1371/journal.pgen.0030136.sg010 (3.2 MB TIF).
Table S1. The 26 Ubiquitous Distal DNaseI HS That Overlap CTCF
ChIP-Chip Hits
Found at doi:10.1371/journal.pgen.0030136.st001 (77 KB DOC).
Table S2. Contingency Tables of DNaseI HS versus CTCF Hits
Found at doi:10.1371/journal.pgen.0030136.st002 (29 KB DOC).
Table S3. DNaseI HS Sites Used in Enhancer-Blocking Assay (hg17
Coordinates)
Found at doi:10.1371/journal.pgen.0030136.st003 (39 KB DOC).
Table S4. Enrichment of AP-1 Motif (TGASTCA) in DNaseI HS Sites
That Overlap p300 Hits
Found at doi:10.1371/journal.pgen.0030136.st004 (27 KB DOC).
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